Detalles de la búsqueda
1.
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
N Engl J Med
; 385(13): 1184-1195, 2021 09 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34347950
2.
Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19.
J Infect Dis
; 227(1): 23-34, 2022 12 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35895508
3.
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
JAMA
; 327(5): 432-441, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35029629
4.
Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants.
Clin Infect Dis
; 73(11): e4400-e4408, 2021 12 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32897368
5.
A Prospective Study of Key Correlates for Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2.
Open Forum Infect Dis
; 10(7): ofad271, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37416758
6.
Nasopharyngeal Viral Load Is the Major Driver of Incident Antibody Immune Response to SARS-CoV-2 Infection.
Open Forum Infect Dis
; 10(12): ofad598, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38111750
7.
Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double-Blind Trial.
Open Forum Infect Dis
; 10(5): ofad211, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37229174
8.
Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration.
Nat Commun
; 14(1): 3605, 2023 06 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37330602
9.
Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial.
Nat Med
; 29(10): 2615-2624, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37770652
10.
Virologic Efficacy of Casirivimab and Imdevimab COVID-19 Antibody Combination in Outpatients With SARS-CoV-2 Infection: A Phase 2 Dose-Ranging Randomized Clinical Trial.
JAMA Netw Open
; 5(8): e2225411, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35969402
11.
Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19.
Int J Infect Dis
; 122: 585-592, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35788416
12.
Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial.
Lancet Infect Dis
; 22(10): 1444-1454, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35803290
13.
Subcutaneous REGEN-COV Antibody Combination in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
medRxiv
; 2021 Sep 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34159343
14.
Subcutaneous REGEN-COV Antibody Combination for Covid-19 Prevention.
medRxiv
; 2021 Jun 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34159344
15.
Pharmacokinetics and Pharmacodynamics of Garetosmab (Anti-Activin A): Results From a First-in-Human Phase 1 Study.
J Clin Pharmacol
; 60(11): 1424-1431, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32557665
16.
Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: A Phase III, double-blind, multicenter, randomized, non-inferiority study.
Hum Vaccin Immunother
; 12(9): 2278-88, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27322354
17.
Comparative Assessment of a Single Dose and a 2-dose Vaccination Series of a Quadrivalent Meningococcal CRM-conjugate Vaccine (MenACWY-CRM) in Children 2-10 Years of Age.
Pediatr Infect Dis J
; 35(1): e19-27, 2016 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26398741
18.
Safety and immunogenicity of typhoid fever and yellow fever vaccines when administered concomitantly with quadrivalent meningococcal ACWY glycoconjugate vaccine in healthy adults.
J Travel Med
; 22(1): 48-56, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25308927
19.
Non-inferiority of mammalian cell-derived quadrivalent subunit influenza virus vaccines compared to trivalent subunit influenza virus vaccines in healthy children: a phase III randomized, multicenter, double-blind clinical trial.
Int J Infect Dis
; 41: 65-72, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26585940
20.
Immunogenicity and safety of concomitant administration of a combined hepatitis A/B vaccine and a quadrivalent meningococcal conjugate vaccine in healthy adults.
J Travel Med
; 22(2): 105-14, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25483566